A similar conclusion comes from a separate study using an engineered high-mutational load murine mammary tumor model (61), in which B cells, CD4 cells, and CD8 cells contributed to checkpoint blockade mediated tumor control. The gene discussed is CD8A; the disease is neoplasm.